NCT02431377View on ClinicalTrials.gov

Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Infant Formula Intolerance
Interventions
OTHER

S-26 Gold

A commercial whey protein dominant, first age formula, containing whey protein concentrate with alpha-lactalbumin

Trial Locations (1)

1780

Asian Hospital and Medical Center, Alabang

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT02431377 - Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula | Biotech Hunter | Biotech Hunter